About us
The peak you cannot explain is our starting point.
Synthesis Analytics is a research-driven chemistry company. We make the compounds that let analytical teams put a name to every peak in a chromatogram — and the documentation that lets them defend it.
Who we are
A chemistry company, not a catalogue reseller.
Impurity standards sit at an awkward point in pharmaceutical development. They are needed in milligram quantities, at high purity, with complete structural proof — and usually at short notice, because nobody plans for the peak that appears at month three of a stability study.
Synthesis Analytics exists for exactly that moment. We synthesise, isolate and characterise API impurities, degradation products, process intermediates and pharmacopoeial reference standards, and we supply them with the analytical package a filing actually needs: assigned potency, NMR, mass spectrometry, chromatographic purity and the method conditions behind each number.
Our catalogue currently runs to 912 compounds across 12 therapeutic areas — statins and sartans, macrolides and cephalosporins, gliflozins and gliptins, antipsychotics, antiretrovirals and the long tail of isomers, N-oxides and dimers that never make it onto a monograph but always make it onto a chromatogram.
Everything else is made to order. If the compound does not exist yet, our chemists will propose a route, tell you honestly what the risks are, and commit to a date before starting.
Our mission
To make well-characterised impurity standards ordinary rather than exceptional — available quickly, documented completely, and priced so that good analytical practice is never the expensive option.
Our vision
A reference library deep enough that no analytical chemist in the region has to abandon an investigation because the standard could not be sourced in time.
“Give us the retention time, the mass and the conditions. That is usually enough to start proposing structures.”
— How most of our projects begin
- Catalogued compounds
- 912+
- Parent drug molecules
- 141+
- Therapeutic areas
- 12
- Years of combined experience
- 35+
How we work
Four things we refuse to compromise on.
Identity before quantity
A number on a certificate means nothing without the spectra that justify it. Structure comes first, potency second, paperwork third — in that order, every time.
Built for the auditor
We assume every batch we release will one day be defended in front of a regulator, and we prepare the documentation accordingly.
Dates we can keep
We would rather quote an honest twelve weeks than an optimistic six. A committed date is agreed before any chemistry starts.
Chemists answer the phone
Technical enquiries reach the people who ran the reaction, not a sales desk reading from a datasheet.
Capability
What sits behind the catalogue.
Synthesis, purification and characterisation under one roof, so a compound never has to leave the building between being made and being proven.
Synthetic chemistry
- Multi-step organic synthesis
- Air- and moisture-sensitive handling
- Milligram to multi-gram scale
- Route scouting and optimisation
Purification
- Preparative HPLC
- Column and flash chromatography
- Recrystallisation and trituration
- Chiral separation
Characterisation
- NMR — ¹H, ¹³C and 2D
- LC-MS and HRMS
- HPLC / UPLC and GC
- FT-IR and melting point
Documentation
- Characterisation protocols
- Certificates of Analysis
- GHS-format safety data sheets
- Regulatory query support
Coverage
Where the catalogue is deepest.
Depth follows demand — the areas where regulators ask the most questions are the areas where we hold the most standards.
Anti-Infectives
23125% of the catalogue
Cardiovascular
19021% of the catalogue
CNS & Neurology
16919% of the catalogue
Diabetes & Endocrine
718% of the catalogue
Respiratory & Allergy
505% of the catalogue
Gastrointestinal
435% of the catalogue
Hormones & Steroids
374% of the catalogue
Oncology & Immunology
364% of the catalogue
Ophthalmology & Dermatology
324% of the catalogue
Urology & Nephrology
303% of the catalogue
Analgesia & Anti-Inflammatory
172% of the catalogue
Building Blocks & Intermediates
61% of the catalogue
